|
Goserelin Clinical Trials
10 actively recruiting trials across 4 locations
Also known as: GnRH agonist, Goserelin acetate, ICI-118630, Zoladex
Other4 trials
Birmingham, Alabama2 trials
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Central Alabama Research
Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
University of Alabama at Birmingham Cancer Center
Phase 3
Phoenix, Arizona2 trials
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Mayo Clinic Arizona
Phase 2
Ann Arbor, Michigan1 trial
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
University of Michigan Comprehensive Cancer Center
Phase 2
St Louis, Missouri1 trial
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Washington University School of Medicine
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.